p73 isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis
Open Access
- 10 June 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 123 (5), 1060-1067
- https://doi.org/10.1002/ijc.23619
Abstract
The secreted mitogen vascular endothelial growth factor, VEGF, plays a pivotal role in angiogenesis. Hypoxia, inactivation of p53 and oncogenic K‐Ras induce VEGF expression. Other factors such as p73 may also affect VEGF levels. Curiously, p73 may also regulate angiogenesis by affecting the expression of the pigment epithelium‐derived factor, PEDF. Additionally, VEGF might harbor additional functions through the activation of E2F transcription factors. Recently, a new VEGF variant formed by alternative splicing, VEGF165b, has been described as exerting anti‐angiogenic activity. We study here whether p73 isoforms levels ‐TAp73 and ΔTAp73‐ and p53 and K‐Ras status affect the expression of the above‐mentioned angiogenesis‐related genes (through the correlation between their expressions), the prognostic value of VEGF165b and PEDF and the correlation between VEGF and E2F‐1 levels. Tumor and normal tissue of 112 colorectal cancer patients was analyzed to evaluate: (i) levels of TAp73, ΔTAp73, VEGF, VEGF165b, PEDF and E2F‐1 by quantitative real‐time RT‐PCR, (ii) p53 status by immunohistochemistry and (iii) mutations in the first exon of K‐Ras by PCR‐SSCP. Tumor characteristics were examined in each patient. Associations were observed between: (i) specific p73 isoforms and VEGF and VEGF165b expression; (ii) ΔEx2p73 variant and downregulation of PEDF; (iii) VEGF and PEDF expression; (iv) inactive p53 and VEGF165b levels; (v) oncogenic K‐Ras and PEDF downregulation; (vi) E2F‐1 and VEGF expressions; (vii) VEGF165b downregulation and poor prognosis parameters of tumors. We conclude that the levels of p73 isoforms could affect the expression of VEGF, VEGF165b and PEDF. This scenario becomes complicated because a feedback between VEGF and PEDF may exist. VEGF may activate the E2F‐1 factor. Mutations in K‐Ras could negatively regulate PEDF expression. p53 inactivation might result in compensatory mechanisms such as over‐expression of VEGF165b. Our data support the role of VEGF165b as a tumor suppressor factor in colorectal carcinogenesis and its possible prognosis value.This publication has 40 references indexed in Scilit:
- Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanomaBritish Journal of Cancer, 2007
- ΔTAp73 Upregulation Correlates With Poor Prognosis in Human Tumors: Putative In Vivo Network Involving p73 Isoforms, p53, and E2F-1Journal of Clinical Oncology, 2006
- Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cellsLife Sciences, 2005
- Identification of pigment epithelium-derived factor as a direct target of the p53 family member genesOncogene, 2005
- Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinomaHepatology, 2004
- Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational statusGenes, Chromosomes and Cancer, 2001
- Expression of the vascular endothelial growth factor gene is inhibited by p73Oncogene, 2000
- VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular MatrixOnline Journal of Public Health Informatics, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Vascular endothelial growth factorTrends in Cardiovascular Medicine, 1993